AAAAAA
Results:
1-25
|
Results: 25
Authors:
Buclin, T
Mazzocato, C
Berney, A
Stiefel, F
Citation: T. Buclin et al., Psychopharmacology in supportive care of cancer: a review for the clinician IV. Other psychotropic agents, SUPP CARE C, 9(4), 2001, pp. 213-222
Authors:
Buclin, T
Cosma, M
Appenzeller, M
Jacquet, AF
Decosterd, LA
Biollaz, J
Burckhardt, P
Citation: T. Buclin et al., Diet acids and alkalis influence calcium retention in bone, OSTEOPOR IN, 12(6), 2001, pp. 493-499
Authors:
Marzolini, C
Telenti, A
Decosterd, L
Biollaz, J
Buclin, T
Citation: C. Marzolini et al., 'Efavirenz plasma levels can predict treatment failure and central nervoussystem side effects in HIV-1-infected patients', AIDS, 15(9), 2001, pp. 1193-1194
Authors:
Marzolini, C
Telenti, A
Decosterd, LA
Greub, G
Biollaz, J
Buclin, T
Citation: C. Marzolini et al., Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients, AIDS, 15(1), 2001, pp. 71-75
Authors:
Marzolini, C
Buclin, T
Decosterd, LA
Biollaz, J
Telenti, A
Citation: C. Marzolini et al., Nelfinavir plasma levels under twice-daily and three-times-daily regimens:High interpatient and low intrapatient variability, THER DRUG M, 23(4), 2001, pp. 394-398
Authors:
Corpataux, JM
Munafo, A
Buclin, T
Biollaz, J
Mosimann, F
Citation: Jm. Corpataux et al., A preliminary evaluation of the discriminative power of the monoethylglycinexylidide formation test after intravenous and oral administration of lidocaine, TRANSPLAN P, 33(4), 2001, pp. 2557-2562
Authors:
Grouzmann, E
Fathi, M
Gillet, M
de Torrente, A
Cavadas, C
Brunner, H
Buclin, T
Citation: E. Grouzmann et al., Disappearance rate of catecholamines, total metanephrines, and neuropeptide Y from the plasma of patients after resection of pheochromocytoma (vol 47, pg 1075, 2001), CLIN CHEM, 47(9), 2001, pp. 1748-1748
Authors:
Grouzmann, E
Fathi, M
Gillet, M
de Torrente, A
Cavadas, C
Brunner, H
Buclin, T
Citation: E. Grouzmann et al., Disappearance rate of catecholamines, total metanephrines, and neuropeptide Y from the plasma of patients after resection of pheochromocytoma, CLIN CHEM, 47(6), 2001, pp. 1075-1082
Authors:
Buclin, T
Spertini, F
Citation: T. Buclin et F. Spertini, Type IIFNs in human versus mouse, NAT IMMUNOL, 1(4), 2000, pp. 265-265
Authors:
Marzolini, C
Telenti, A
Buclin, T
Biollaz, J
Decosterd, LA
Citation: C. Marzolini et al., Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction, J CHROMAT B, 740(1), 2000, pp. 43-58
Authors:
Buchwalder, PA
Buclin, T
Trinchard, I
Munafo, A
Biollaz, J
Citation: Pa. Buchwalder et al., Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers, J INTERF CY, 20(10), 2000, pp. 857-866
Authors:
Berney, A
Stiefel, F
Mazzocato, C
Buclin, T
Citation: A. Berney et al., Psychopharmacology in supportive care of cancer: a review for the clinician III. Antidepressants, SUPP CARE C, 8(4), 2000, pp. 278-286
Authors:
Mazzocato, C
Stiefel, F
Buclin, T
Berney, A
Citation: C. Mazzocato et al., Psychopharmacology in supportive care of cancer: a review for the clinician - II. Neuroleptics, SUPP CARE C, 8(2), 2000, pp. 89-97
Authors:
Rousso, P
Buclin, T
Nussberger, J
Brunner-Ferber, F
Brunner, HR
Biollaz, J
Citation: P. Rousso et al., Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers, EUR J CL PH, 55(10), 2000, pp. 749-754
Authors:
Liaudet, L
Buclin, T
Jaccard, C
Eckert, P
Citation: L. Liaudet et al., Severe ergotism associated with interaction between ritonavir and ergotamine, BR MED J, 318(7186), 1999, pp. 771-771
Authors:
Mazzocato, C
Buclin, T
Rapin, CH
Citation: C. Mazzocato et al., The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: A randomized double-blind controlled trial, ANN ONCOL, 10(12), 1999, pp. 1511-1514
Authors:
Marzolini, C
Decosterd, LA
Shen, F
Gander, M
Leyvraz, S
Bauer, J
Buclin, T
Biollaz, J
Lejeune, F
Citation: C. Marzolini et al., Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration (vol 42, pg 433, 1998), CANC CHEMOT, 43(5), 1999, pp. 439-440
Authors:
Buclin, T
Buchwalder-Csajka, C
Brunner, HR
Biollaz, J
Citation: T. Buclin et al., Evaluation of noninvasive blood pressure recording by photoplethysmographyin clinical studies using angiotensin challenges, BR J CL PH, 48(4), 1999, pp. 586-593
Authors:
Buchwalder-Csajka, C
Buclin, T
Brunner, HR
Biollaz, J
Citation: C. Buchwalder-csajka et al., Evaluation of the angiotensin challenge methodology for assessing the pharmacodynamic profile of antihypertensive drugs acting on the renin-angiotensin system, BR J CL PH, 48(4), 1999, pp. 594-604
Authors:
Rousso, P
Buclin, T
Nussberger, J
Decosterd, LA
La Roche, SD
Brunner-Ferber, F
Brunner, HR
Biollaz, J
Citation: P. Rousso et al., Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100 240, on endocrine and renal functions in healthy volunteers, J HYPERTENS, 17(3), 1999, pp. 427-437
Authors:
Rothuizen, LE
Buclin, T
Spertini, F
Trinchard, I
Munafo, A
Buchwalder, PA
Ythier, K
Biollaz, J
Citation: Le. Rothuizen et al., Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers, J NEUROIMM, 99(1), 1999, pp. 131-141
Authors:
Dafflon, M
Decosterd, LA
Biollaz, J
Preisig, M
Dufour, H
Buclin, T
Citation: M. Dafflon et al., Trace lithium in mood disorders, J AFFECT D, 54(1-2), 1999, pp. 199-203
Authors:
Voirol, P
Rubin, C
Bryois, C
Kosel, M
Buclin, T
Baumann, P
Citation: P. Voirol et al., Pharmacokinetic consequences of a citalopram treatment discontinuation (vol 21, pg 263, 1999), THER DRUG M, 21(6), 1999, pp. 682-682
Authors:
Voirol, P
Rubin, C
Bryois, C
Kosel, M
Buclin, T
Baumann, P
Citation: P. Voirol et al., Pharmacokinetic consequences of a citalopram treatment discontinuation, THER DRUG M, 21(3), 1999, pp. 263-266
Authors:
Decosterd, LA
Buclin, T
Dafflon, M
Leeman, C
Belaz, N
Magnin, JL
Biollaz, J
Citation: La. Decosterd et al., Determination of trace lithium in human erythrocytes by electrothermal atomic-absorption spectrometry with pyrocoated graphite tubes and integrated platform, J PHARM PHA, 50(6), 1998, pp. 693-701
Risultati:
1-25
|